Raymond James & Associates Acquires 10,004 Shares of ICU Medical, Incorporated (ICUI)

Raymond James & Associates grew its holdings in ICU Medical, Incorporated (NASDAQ:ICUI) by 9.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 116,536 shares of the medical instruments supplier’s stock after acquiring an additional 10,004 shares during the period. Raymond James & Associates’ holdings in ICU Medical were worth $27,891,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. TIAA CREF Investment Management LLC raised its holdings in shares of ICU Medical by 230.8% in the 3rd quarter. TIAA CREF Investment Management LLC now owns 165,570 shares of the medical instruments supplier’s stock worth $46,815,000 after purchasing an additional 115,526 shares during the period. Vanguard Group Inc grew its stake in ICU Medical by 12.0% in the 3rd quarter. Vanguard Group Inc now owns 1,483,501 shares of the medical instruments supplier’s stock valued at $419,459,000 after buying an additional 158,798 shares in the last quarter. First Hawaiian Bank grew its stake in ICU Medical by 19.1% in the 4th quarter. First Hawaiian Bank now owns 954 shares of the medical instruments supplier’s stock valued at $219,000 after buying an additional 153 shares in the last quarter. Bank of Montreal Can grew its stake in ICU Medical by 82.3% in the 4th quarter. Bank of Montreal Can now owns 88,028 shares of the medical instruments supplier’s stock valued at $20,213,000 after buying an additional 39,740 shares in the last quarter. Finally, We Are One Seven LLC purchased a new position in ICU Medical in the 4th quarter valued at approximately $32,000. Institutional investors and hedge funds own 92.90% of the company’s stock.

NASDAQ ICUI opened at $224.59 on Monday. ICU Medical, Incorporated has a 52-week low of $210.94 and a 52-week high of $321.70. The firm has a market cap of $4.63 billion, a PE ratio of 29.13 and a beta of 0.69.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.96 by $0.39. ICU Medical had a net margin of 4.04% and a return on equity of 13.70%. The company had revenue of $330.93 million during the quarter, compared to the consensus estimate of $318.97 million. During the same period in the previous year, the firm posted $2.26 EPS. The firm’s revenue was down 11.0% compared to the same quarter last year. On average, research analysts predict that ICU Medical, Incorporated will post 8.55 earnings per share for the current fiscal year.

A number of research firms recently weighed in on ICUI. TheStreet upgraded shares of ICU Medical from a “c+” rating to a “b” rating in a research note on Friday, May 10th. Zacks Investment Research lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st. BidaskClub lowered shares of ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, May 15th. Finally, Raymond James reduced their price target on shares of ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating for the company in a research report on Friday, March 1st. One investment analyst has rated the stock with a sell rating, two have given a hold rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $281.00.

In other ICU Medical news, COO Christian B. Voigtlander sold 5,348 shares of the business’s stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $227.59, for a total value of $1,217,151.32. Following the completion of the sale, the chief operating officer now directly owns 4,732 shares of the company’s stock, valued at $1,076,955.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Virginia Ruth Sanzone sold 5,277 shares of the business’s stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $232.31, for a total transaction of $1,225,899.87. Following the completion of the sale, the vice president now directly owns 13,167 shares of the company’s stock, valued at $3,058,825.77. The disclosure for this sale can be found here. Insiders have sold a total of 12,318 shares of company stock valued at $2,839,576 over the last ninety days. 11.40% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: “Raymond James & Associates Acquires 10,004 Shares of ICU Medical, Incorporated (ICUI)” was reported by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/05/20/raymond-james-associates-acquires-10004-shares-of-icu-medical-incorporated-icui.html.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Recommended Story: Balance Sheet

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.